Nanicula
Nanicula Inc., established on February 8, 2018, in Wooster, Ohio, focuses on developing nanoparticle-based vaccine technologies for poultry, leveraging intellectual property licensed from The Ohio State University. The company's initial product, the SalNP Adjuvant vaccine, aims to enhance immunological responses in birds through innovative delivery methods.
Led by Dr. Renukaradhya Gourapura as Chief Scientific Officer and supported by a seasoned management team, Nanicula is actively pursuing commercialization opportunities and regulatory pathways for its products. The company operates from the BioHio Research Park incubator facility, where it is positioned to advance its research and development efforts in the veterinary pharmaceutical sector.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.






